News - Sipuleucel-T
2012-04-17 02:27:57
SAN FRANCISCO, April 17, 2012 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic
2011-10-17 11:40:00
SEATTLE, Oct. 17, 2011 /PRNewswire/ - Christopher Henney, Chairman of the Board of Oncothyreon Inc.
The US Oncology Network Affiliated Physicians at Forefront of Cutting-Edge Prostate Cancer Treatment
2011-09-30 09:00:00
THE WOODLANDS, Texas, Sept. 30, 2011 /PRNewswire/ -- David, a 67-year-old father of three and soon to be first-time grandfather, felt too young to be diagnosed with prostate cancer.
2011-09-26 11:41:15
Researchers say that the cost of treating cancer is spiraling out of control and becoming unaffordable in many developed countries.
